Alexion to Report Fourth Quarter and Full Year 2017 Results on Thursday, February 8, 2018

NEW HAVEN, Conn.--()--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2017 on Thursday, February 8, 2018 before the US financial markets open. Following the release of the financial results, Alexion management will conduct a conference call and audio webcast on Thursday, February 8, 2018, at 10:00 a.m. Eastern Time (ET).

To participate in this conference call, dial 800-239-9838 (USA) or 323-794-2551 (International), passcode 7453141 shortly before 10:00 a.m. ET. A replay of the call will be available from 1:00 p.m. ET through a limited time thereafter. The replay number is 888-203-1112 (USA) or 719-457-0820 (International), passcode 7453141. The audio webcast can be accessed on the Investor page of http://ir.alexion.com.

[ALXN-G]

Contacts

Alexion Pharmaceuticals, Inc.
Investors
Elena Ridloff, CFA
Vice President, Investor Relations
(475) 230-3601
or
Catherine Hu
Director, Investor Relations
(475) 230-3599

Release Summary

Alexion to Report Fourth Quarter and Full Year 2017 Results on Thursday, February 8, 2018

Contacts

Alexion Pharmaceuticals, Inc.
Investors
Elena Ridloff, CFA
Vice President, Investor Relations
(475) 230-3601
or
Catherine Hu
Director, Investor Relations
(475) 230-3599